Company Filing History:
Years Active: 2011
Title: Andrew Lister: Innovator in Medicinal Chemistry
Introduction
Andrew Lister is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target beta adrenoreceptors. His work is crucial for advancing treatments for various respiratory diseases.
Latest Patents
Andrew Lister holds a patent for "Bezothiazol derivatives as Beta2 adrenoreceptor agonists." This invention relates to compounds that can be used in the manufacture of medicaments for treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma, and rhinitis. The compounds are designed to act as beta adrenoreceptor agonists, showcasing their potential in therapeutic applications.
Career Highlights
Andrew Lister is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role in the company has allowed him to contribute to innovative research and development in the pharmaceutical sector. With a focus on creating effective treatments, he has established himself as a key figure in his field.
Collaborations
Andrew has worked alongside talented colleagues such as Lilian Alcaraz and Garry Pairaudeau. Their collaborative efforts have further enhanced the research and development initiatives at AstraZeneca AB.
Conclusion
Andrew Lister's contributions to medicinal chemistry and his innovative patent work highlight his importance in the field. His dedication to developing effective treatments for respiratory diseases continues to impact the medical community positively.